 Antibodies, Viral
"Antibodies, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulins produced in response to VIRAL ANTIGENS.
| Descriptor ID |
D000914
|
| MeSH Number(s) |
D12.776.124.486.485.114.254 D12.776.124.790.651.114.254 D12.776.377.715.548.114.254
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Viral".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Viral".
This graph shows the total number of publications written about "Antibodies, Viral" by people in this website by year, and whether "Antibodies, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 | | 1997 | 0 | 4 | 4 | | 1998 | 2 | 3 | 5 | | 1999 | 2 | 3 | 5 | | 2000 | 1 | 0 | 1 | | 2001 | 2 | 4 | 6 | | 2002 | 0 | 2 | 2 | | 2003 | 2 | 6 | 8 | | 2004 | 1 | 6 | 7 | | 2005 | 2 | 4 | 6 | | 2006 | 3 | 5 | 8 | | 2007 | 5 | 6 | 11 | | 2008 | 2 | 7 | 9 | | 2009 | 2 | 11 | 13 | | 2010 | 2 | 5 | 7 | | 2011 | 6 | 3 | 9 | | 2012 | 6 | 4 | 10 | | 2013 | 4 | 4 | 8 | | 2014 | 4 | 7 | 11 | | 2015 | 9 | 6 | 15 | | 2016 | 2 | 7 | 9 | | 2017 | 5 | 14 | 19 | | 2018 | 6 | 13 | 19 | | 2019 | 9 | 9 | 18 | | 2020 | 13 | 16 | 29 | | 2021 | 22 | 25 | 47 | | 2022 | 3 | 35 | 38 | | 2023 | 0 | 13 | 13 | | 2024 | 9 | 16 | 25 | | 2025 | 14 | 12 | 26 | | 2026 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies, Viral" by people in Profiles.
-
Roubinian NH, Plimier C, Spencer BR, Bravo M, Custer B, D'Alessandro A, Kleinman S, Norris PJ, Busch MP. Transfusion requirements in recipients of plasma units from blood donors with recent SARS-CoV-2 infection. Transfusion. 2026 Apr; 66(4):651-655.
-
Kpetigo AD, Alexandre M, Camara A, Beavogui A, Doumbia S, Kieh M, Leigh B, Sow S, Wittkop L, Soutthiphong AA, Berry IM, Fleck S, Akoo P, Hamze B, Watson-Jones D, Kuhn JH, Greenwood B, Richert L, Yazdanpanah Y, Lévy Y, Thiébaut R, Prague M, Lhomme E. Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial. PLoS Negl Trop Dis. 2026 Jan; 20(1):e0013950.
-
Toews E, Shaikh S, Akter S, Zhang C, Selemon A, Arora RK, Bobrovitz N, Jaenisch T, Ware H, Whelan MG. Serological and viral prevalence of Oropouche virus (OROV): A systematic review and meta-analysis from 2000-2024 including human, animal, and vector surveillance studies. PLoS Negl Trop Dis. 2025 Dec; 19(12):e0013340.
-
Muthuraman K, Jackman M, Liang Y, Garrett ME, Cui H, Nguyen LVH, Ivanochko D, Ye C, Pino PA, Hicks A, Maingot B, Yusko E, Benzeno S, Martínez-Sobrido L, Torrelles JB, Gilbert AE, Rubin BER, Keitany G, Jetha A, Julien J-P. Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions. J Virol. 2025 12 23; 99(12):e0152325.
-
Chiu CY, Chesdachai S, Beam E, Henao-Martínez AF. Seroprevalence and Incidence of Measles, Mumps, and Rubella in Adult Solid Organ Transplant Recipients in the United States: A Large Database Analysis. Transplantation. 2026 Feb 01; 110(2):e464-e471.
-
Chandrasekaran P, Berry IM, Callier V, Anthony SM, Hensley K, Kuhn JH, Shaw-Saliba K, Kennedy SB, Kieh M, Browne SM, Crozier I, Davey RT, Lane HC, Hensley LE, Follmann DA. Vector-Induced Humoral Responses After rVSV?G-ZEBOV-GP Immunization Identify Vaccinated Individuals and Correlate With Ebola Virus Glycoprotein Antibodies. J Infect Dis. 2025 Oct 15; 232(4):1004-1014.
-
Yee DS, Davies JP, VanBlargan LA, Rahmberg AR, Burgomaster KE, Brooks K, Flynn JK, Shue B, Ortiz AM, Schaughency P, Best SM, Pierson TC, Brenchley JM. Oropouche virus efficiently replicates and is immunostimulatory in vivo in nonhuman primate species. Sci Adv. 2025 Sep 19; 11(38):eadx9405.
-
Swingle KL, Hamilton AG, Han X, Liao KC, Safford HC, Thatte AS, Geisler HC, Xu J, Saw TY, Wan Y, Mitchell MJ. Circular RNA lipid nanoparticle vaccine against SARS-CoV-2. Proc Natl Acad Sci U S A. 2025 Sep 23; 122(38):e2505718122.
-
Ouyang WO, Lv H, Liu W, Lei R, Mou Z, Pholcharee T, Talmage L, Tong M, Ji W, Wang Y, Dailey KE, Gopal AB, Choi D, Ardagh MR, Rodriguez LA, Guthmiller JJ, Dai X, Wu NC. High-throughput synthesis and specificity characterization of natively paired influenza hemagglutinin antibodies with oPool+ display. Sci Transl Med. 2025 Sep 03; 17(814):eadt4147.
-
Baum HE, Santopaolo M, Francis O, Milodowski EJ, Entwistle K, Oliver E, Hitchings B, Diamond D, Thomas AC, Mitchell RE, Kibble M, Gupta K, Di Bartolo N, Klenerman P, Brown A, Morales-Aza B, Oliver J, Berger I, Toye AM, Finn A, Goenka A, Davidson AD, Ring S, Molloy L, Lewcock M, Northstone K, Roth F, Timpson NJ, Wooldridge L, Halliday A, Rivino L. Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants. J Infect Dis. 2025 Aug 14; 232(2):e327-e340.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|